Diabetes is one of the chronic diseases targeted by telemedicine applications. The remote monitoring of important physiological values may help lessen health care costs and has the potential for improving care for diabetes patients. A significant decrease in HbA1c levels through the use of telemedicine when compared to standard treatment has previously been postulated. However, the technology's impact on clinical events or cost-effectiveness is not yet clarified. Even though telemedicine harbors the potential of improving care in diabetic patients, some detrimental effects may accompany its implementation. The alteration of the communication between patients and caregivers may adversely affect the therapeutic relationship which is a cornerstone of diabetes treatment.